| Filed On | Filing |
|---|---|
| 10 Feb 2021 |
8-K/A: Departure/Election of Directors or Officers; Compensation
On January 8, 2021, Nancy Thornberry was appointed to the Board of Directors (the “Board”) of Denali Therapeutics Inc. (the “Company”). The election of Ms. Thornberry was reported under Item 5.02 of the Company’s Current Report on Form 8... |
| 20 Aug 2020 |
8-K/A: Submission of Matters to a Vote of Security Holders
As previously reported in the Original Form 8-K, in a non-binding advisory vote on the frequency of future say on pay votes held at the 2020 Annual Meeting, 41,684,618 shares voted for one year, 29,849 shares voted for 2 years, 39,535,17... |
Loading...